Browse content
Table of contents
Actions for selected chapters
- Full text access
- Book chapterNo access
INTRODUCTION
L. SZEKERES
Pages 3-4 - Book chapterNo access
THE CYCLIC AMP—PROTEIN KINASE SYSTEM IN ACUTE MYOCARDIAL ISCHAEMIA
A. WOLLENBERGER, S. BARTEL and E.-G. KRAUSE
Pages 5-12 - Book chapterNo access
CELLULAR ELECTROPHYSIOLOGICAL DISORDERS IN ACUTE MYOCARDIAL ISCHAEMIA AND THEIR MODIFICATION BY DRUGS
J.GY. PAPP and L. SZEKERES
Pages 13-24 - Book chapterNo access
ANTIARRHYTHMIC EFFECTS OF POSSIBLE ANTI-ISCHEMIC DRUGS
K. HASHIMOTO, H. MITSUHASHI, ... K. AKIYAMA
Pages 25-31 - Book chapterNo access
PROTECTION OF THE ISCHAEMIC HEART. PREVENTION OF PRIMARY VENTRICULAR FIBRILLATION
L. SZEKERES, M. KOLTAI, ... T. FAZEKAS
Pages 33-43 - Book chapterNo access
REFLECTIONS ON THE MODE OF ACTION OF BETA-ADRENOCEPTOR ANTAGONISTS IN PROLONGING LIFE AFTER ACUTE MYOCARDIAL INFARCTION
J.D. FITZGERALD
Pages 45-51 - Book chapterAbstract only
CARDIOPROTECTIVE AND CEREBROPROTECTIVE EFFECT OF LIPOCORTIN-LIKE SUBSTANCES
M. KOLTAI, I. LEPRAN, ... L. SZEKERES
Pages 53-59 - Book chapterNo access
ANTIISCHAEMIC ACTIONS OF CALCIUM ANTAGONISTS
T. GODFRAIND
Pages 61-66 - Book chapterNo access
CARDIO-PROTECTIVE AND -NONPROTECTIVE EFFECTS OF DRUGS DURING ANOXIA AND REOXYGENATION
M. SIESS
Pages 67-72 - Book chapterNo access
CARDIAC GLYCOSIDES AND MYOCARDIAL ISCHAEMIA
K. GREEFF
Pages 73-79 - Book chapterNo access
PHARMACOLOGICAL CONTROL OF THROMBOTIC PROCESSES FOR PREVENTION OF MYOCARDIAL ISCHAEMIA
F. MARKWARDT
Pages 81-87 - Book chapterNo access
THE PHARMACOLOGICAL PROTECTION OF THE ISCHAEMIC MYOCARDIUM. PROBLEMS AND POSSIBILITIES
J.R. PARRATT
Pages 89-98 - Book chapterNo access
ETHACIZINE: ANTIARRHYTHMIC AND ANTIISCHAEMIC PROPERTIES
N.V. KAVERINA
Pages 99-102 - Book chapterNo access
EFFECTS OF DILTIAZEM AND VERAPAMIL IN A NEW CANINE MODEL OF MYOCARDIAL INFARCTION
AGNES VÉGH, ÉVA UDVARY and L. SZEKERES
Pages 103-107 - Book chapterNo access
POSSIBLE DIFFERENCES AMONG THE DRUG-INDUCED RESPONSES OF THE DESCENDING AND CIRCUMFLEX CORONARY ARTERIES IN THE ANAESTHETIZED DOG
IREN KRASSÓI, ÉVA UDVARY and L. SZEKERES
Pages 109-112 - Book chapterNo access
BETA-ADRENOLYTIC WITHDRAWAL REBOUND PHENOMENON: AN INTRODUCTION
F. INCZINGER and P. Ŝar;VEC
Pages 113-116 - Book chapterNo access
A CONTRIBUTION TO THE MECHANISM OF BETA-ADRENOLYTIC WITHDRAWAL SYNDROME
E. BÉDEROVÁ, I. TUMOVÁ and P. Ŝar;VEC
Pages 117-120 - Book chapterNo access
ALTERATIONS IN THE EFFICACY OF BETA-ADRENOTROPIC DRUGS DUE TO CHANGES IN THE TONE OF THE AUTONOMIC NERVOUS SYSTEM
J. SEGINKO, P. Ŝar;VEC, ... F. INCZINGER
Pages 121-124 - Book chapterNo access
ARTERIOVENOUS DIFFERENCE IN THE INHIBITION OF PLATELET AGGREGATION BY THE ANTIANGINAL DRUG: CH-102
J. PATARICZA, P. BOR and L. SZEKERES
Pages 125-128 - Book chapterNo access
INHIBITION OF ADENYLATE CYCLASE BY Ca2+ IN THE ISCHAEMIC MYOCARDIUM. A CONCEPT OF PROTECTION BY Ca2+ CHANNEL AND β-BLOCKADE
L. WILL-SHAHAB, I. KÜTTNER, ... S. BARTEL
Pages 129-133 - Book chapterNo access
PROTECTIVE EFFECT OF CALCIUM ANTAGONISTS ON ISCHAEMIC MYOCARDIAL METABOLISM DUE TO VASOPRESSIN INDUCED CORONARY SPASM
I. TAKÁTS and L. SZEKERES
Pages 135-138 - Book chapterNo access
INHIBITION OF CAMP-PHOSPHODIESTERASE FROM HEART AND CORONARY ARTERIES BY A NEW TRAPIDIL DERIVATIVE
E.-G. KRAUSE, H. TENOR, ... H.J. MEST
Pages 139-142 - Book chapterNo access
COMPARISON OF THREE CALCIUM ANTAGONISTS, VERAPAMIL, DILTIAZEM AND FENDILINE ON THE ENERGETIC STATE OF ISOLATED LANGENDORFF RAT HEART
Á. TÓSAKI, I. TAKÁTS, ... L. SZEKERES
Pages 143-146 - Book chapterNo access
EFFECT OF IS, A WATER SOLUBLE DERIVATIVE OF INDOMETHACIN, ON THE OUTCOME OF THE VERY EARLY PHASE OF EXPERIMENTAL MYOCARDIAL INFARCTION IN CONSCIOUS RATS
ILONA KAHÁNNÉ-LÁSZLÓ, I. LEPRÁN, ... L. SZEKERES
Pages 147-150 - Book chapterNo access
THE USE OF VOLTAGE CLAMP IN THE TESTING OF ANTIARRHYTHMIC DRUGS
K. KELEMEN and RAISA MARKO
Pages 151-157 - Book chapterNo access
INTRACELLULAR ELECTROPHYSIOLOGICAL EFFECTS OF AMIODARONE AFTER ACUTE AND CHRONIC APPLICATION IN GUINEA PIG VENTRICULAR AND DOG PURKINJE FIBERS
A. VARRÓ, Y. NAKAYA, ... B. SURAWICZ
Pages 159-162 - Book chapterNo access
ELECTRICAL AND MECHANICAL ACTIVITY OF THE MYOCARDIUM AS AFFECTED BY CH-101, AN ANTIARRHYTHMIC AGENT WITH PREFERENTIAL SUPRAVENTRICULAR ACTION
O. HÁLA, J.Gy. PAPP and L. SZEKERES
Pages 163-167 - Book chapterNo access
INVOLVEMENT OF THE CENTRAL NICOTINIC RECEPTORS IN THE GENESIS OF THE CENTROGENIC CARDIAC ARRHYTHMIAS IN RATS
B. CUPARENCU, D.N. SAFTA, ... A. VERESS
Pages 169-172 - Book chapterNo access
MORPHINE AND TIFLUADOM-INDUCED CENTROGENIC ARRHYTHMIAS IN ANAESTHETIZED RATS
D.N. SAFTA, B. CUPARENCU and VIORICA ARUSTEI
Pages 173-176 - Book chapterNo access
STRUCTURE—ANTIARRHYTHMIC ACTIVITY RELATIONSHIP OF THE AMINO-ALCOHOL DERIVATIVES
B. CEBO, J. KRUPINSKA, ... M. ECKSTEIN
Pages 177-181 - Book chapterNo access
LONG TERM-TREATMENT OF CARDIAC ARRHYTHMIAS WITH NADOLOL
H. ADAMSKA-DYNIEWSKA, W. TKACZEWSKI, ... S. DZIEKANSKI
Pages 183-186 - Book chapterNo access
ELECTROPHYSIOLOGICAL BASES OF ANTIFIBRILLATORY ACTION OF CHINOIN-103
J. MÉSZÁROS, J. SZEGI, ... G. KOVACS
Pages 187-190 - Book chapterNo access
MICROELECTROPHYSIOLOGICAL PROCEDURE FOR THE ANALYSIS OF DRUG EFFECTS ON THE ATRIOVENTRICULAR CONDUCTING SYSTEM
M. NÉMETH, J.GY. PAPP and L. SZEKERES
Pages 191-195 - Book chapterNo access
SERUM LEVELS OF DIGOXIN DURING COMBINED TREATMENT WITH DIGOXIN AND AMIODARONE
H. ADAMSKA-DYNIEWSKA, W. TKACZEWSKI and R. BRZOZOWSKI
Pages 197-199 - Book chapterNo access
THE INOTROPIC EFFECT OF ISOPROTERENOL AND DOPAMINE UNDER DIFFERENT LEVELS OF OXYGENATION
V.V. TKACHUK
Pages 201-204 - Book chapterNo access
THE INFLUENCE OF DOXORUBICIN COMBINED WITH OTHER DRUGS ON HAEMODYNAMIC PARAMETERS IN RABBITS
J. DRZEWOSKI
Pages 205-209 - Book chapterNo access
NEW ANTIARRHYTHMIC AGENT WITH POSITIVE CARDIAC ACTIONS (GYKI-38 233)
M. KÜRTHY, G. RABLOCZKY, ... I. ÉRCZY
Pages 211-215 - Book chapterNo access
CARDIAC ELECTROPHYSIOLOGICAL EFFECTS OF LYSOLECITHIN, AN ISCHAEMIC METABOLITE, ON RABBIT ATRIAL AND VENTRICULAR MYOCARDIUM
T. FAZEKAS, M. NÉMETH, ... L. SZEKERES
Pages 217-222 - Book chapterNo access
ACUTE AND CHRONIC EFFECTS OF IPRATROPIUM BROMIDE (ITROP) IN PATIENTS WITH BRADYCARDIA
M. BÉKÉS and K. ZÁMOLYI
Pages 223-226 - Book chapterNo access
MYOCARDIAL PROTECTION BY COMPUTERISED LONG-TIME CONTROLLING OF THE MYOCARDIAL GLUCOSE-, INSULIN-, FATTY ACID-SUPPLY IN MAN
R. MÖRICKE, M. KIESEWETTER, ... V. DETSCHEV
Pages 227-231 - Book chapterNo access
CHEMICAL AND BIOCHEMICAL PARAMETERS ASSOCIATED WITH NEW CARDIOVASCULAR DRUGS
G. DE STEVENS
Pages 245-249 - Book chapterNo access
LIST OF CONTRIBUTORS
Pages 233-236 - Book chapterNo access
SUBJECT INDEX
Pages 237-242 - Book chapterNo access
LIST OF CONTRIBUTORS
Pages 409-414 - Book chapterNo access
SUBJECT INDEX
Pages 415-417
About the book
Description
Advances in Pharmacological Research and Practice, Volume 1: Pharmacological Protection of the Myocardium presents the proceedings of the 4th Congress of the Hungarian Pharmacological Society, held in Budapest, Hungary in 1985. This book presents a comprehensive view of the development in the fields of pharmacological protection of the myocardium and the pharmacology of the vascular system. Organized into two sections encompassing 70 chapters, this volume begins with an overview of the ischemic biochemical changes with emphasis on the role of cAMP and the protein kinase system. This text then explores the cellular electrophysiological disorders seen in acute myocardial ischemia as well as their pharmacological modification. Other chapters consider the prevention of primary ventricular fibrillation that includes measures aimed at maintaining electrical stability. The final chapter deals with drugs affecting beneficially the pathological lipoprotein levels. This book is a valuable resource for cardiologists and pharmacologists.
Advances in Pharmacological Research and Practice, Volume 1: Pharmacological Protection of the Myocardium presents the proceedings of the 4th Congress of the Hungarian Pharmacological Society, held in Budapest, Hungary in 1985. This book presents a comprehensive view of the development in the fields of pharmacological protection of the myocardium and the pharmacology of the vascular system. Organized into two sections encompassing 70 chapters, this volume begins with an overview of the ischemic biochemical changes with emphasis on the role of cAMP and the protein kinase system. This text then explores the cellular electrophysiological disorders seen in acute myocardial ischemia as well as their pharmacological modification. Other chapters consider the prevention of primary ventricular fibrillation that includes measures aimed at maintaining electrical stability. The final chapter deals with drugs affecting beneficially the pathological lipoprotein levels. This book is a valuable resource for cardiologists and pharmacologists.
Details
ISBN
978-0-08-034190-3
Language
English
Published
1986
Copyright
Copyright © 1986 Elsevier Ltd. All rights reserved.
Imprint
Pergamon